Ir para o conteúdo
AI.info

AI Tools

Lunit SCOPE IO

Lunit SCOPE IO: preços, capacidades, atualizações e alternativas, lidos nas páginas do próprio desenvolvedor.

O site de Lunit SCOPE IO

Em inglês

Key facts

Price
Not stated on the maker’s pages
Free plan
Not stated on the maker’s pages
Platforms
Not stated on the maker’s pages
API
Not stated on the maker’s pages
Open source
Not stated on the maker’s pages
Last update
23 Oct 2026 Read on lunit.io

Lunit SCOPE IO uses AI to analyze H&E whole-slide pathology images for immuno-oncology research and biomarker discovery. It measures immune phenotypes and features such as tumor and stromal regions, immune-cell distribution, tertiary lymphoid structures, and tumor-stroma patterns.

Biopharma and research teams can use its results to investigate biomarkers and immunotherapy response. Lunit labels the product for research use only, not for diagnostic procedures or decisions. The official product page does not list a price; contact Lunit for product details.

Category
Research & Education
Read from the maker’s pages
2026-11-18

Company

Lunit Inc.

Features

  • Classifies immune phenotypes as Inflamed, Immune-Excluded, or Immune-Desert
  • Analyzes H&E whole-slide images for tumor-microenvironment features
  • Identifies tumor cells, lymphocytes, macrophages, fibroblasts, and endothelial cells
  • Measures tumor-infiltrating lymphocytes and their distribution
  • Identifies tertiary lymphoid structures, necrosis, and mitosis
  • Analyzes tumor-stroma ratio, borders, and spatial patterns
  • Supports biomarker discovery and immunotherapy research

Use cases

  • Explore immune biomarkers from H&E slides in oncology research
  • Measure tumor-microenvironment features across cancer studies
  • Assess immune-cell patterns when investigating immunotherapy response
  • Support biomarker discovery for immunotherapy clinical trials
  • Compare tissue features in translational research programs

Latest updates

More from Lunit Inc.

  • Lunit INSIGHT CXR

    AI software that analyzes chest X-rays to flag abnormalities and likely normal cases, helping clinicians review and prioritize studies.

Questions about Lunit SCOPE IO

Is Lunit SCOPE IO still available?

Yes, as of 18 Nov 2026: its maker’s pages were read that day and carried no notice that Lunit SCOPE IO has ended.

What changed recently in Lunit SCOPE IO?

The latest entry in its maker’s changelog: 23 Oct 2026, “Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncolo…”. Before it: 15 Oct 2026, “Lunit SCOPE Reveals HER2 Expression Differences Linked to Treatment Response Beyond Conventional Testing in Nature Medicine Study”. Changelog checked on 14 Nov 2026.

Sources

Not confirmed

Prices
Search did not find an official pricing page for Lunit SCOPE IO.
No official tier names or prices were found.
Free plan
The product page does not state whether a free tier exists.
API
The product page does not state whether an API is available.
Open source
The product page does not state an open-source license.
Platforms
The product page does not specify supported platforms.
Latest version
No current product version or model name was listed.
Official website